Small,
Journal Year:
2024,
Volume and Issue:
20(26)
Published: Jan. 26, 2024
Abstract
Spinal
cord
injury
(SCI)
often
leads
to
cell
death,
vascular
disruption,
axonal
signal
interruption,
and
permanent
functional
damage.
Currently,
there
are
no
clearly
effective
therapeutic
options
available
for
SCI.
Considering
the
inhospitable
SCI
milieu
typified
by
ischemia,
hypoxia,
restricted
neural
regeneration,
a
novel
injectable
hydrogel
system
containing
conductive
black
phosphorus
(BP)
nanosheets
within
lipoic
acid‐modified
chitosan
matrix
(LAMC)
is
explored.
The
incorporation
of
tannic
acid
(TA)‐modified
BP
(BP@TA)
into
LAMC
significantly
improved
its
conductivity.
Further,
embedding
bicyclodextrin‐conjugated
tazarotene
drug,
showcased
amplified
angiogenic
potential
in
vitro.
In
rat
model
complete
SCI,
implantation
LAMC/BP@TA
markedly
recovery
motor
function.
Immunofluorescence
evaluations
confirmed
that
composite
facilitated
endogenous
angiogenesis
neurogenesis
at
site.
Collectively,
this
work
elucidates
an
innovative
drug‐incorporated
enriched
with
BP,
underscoring
foster
regeneration.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: June 26, 2023
Abstract
Spinal
cord
injury
(SCI)
remains
a
severe
condition
with
an
extremely
high
disability
rate.
The
challenges
of
SCI
repair
include
its
complex
pathological
mechanisms
and
the
difficulties
neural
regeneration
in
central
nervous
system.
In
past
few
decades,
researchers
have
attempted
to
completely
elucidate
mechanism
identify
effective
strategies
promote
axon
circuit
remodeling,
but
results
not
been
ideal.
Recently,
new
SCI,
especially
interactions
between
immune
cell
responses,
revealed
by
single-cell
sequencing
spatial
transcriptome
analysis.
With
development
bioactive
materials
stem
cells,
more
attention
has
focused
on
forming
intermediate
networks
reconstruction
than
promoting
axonal
corticospinal
tract.
Furthermore,
technologies
control
physical
parameters
such
as
electricity,
magnetism
ultrasound
constantly
innovated
applied
fate
regulation.
Among
these
advanced
novel
technologies,
therapy,
biomaterial
transplantation,
electromagnetic
stimulation
entered
into
stage
clinical
trials,
some
them
already
treatment.
this
review,
we
outline
overall
epidemiology
pathophysiology
expound
latest
research
progress
related
detail,
propose
future
directions
for
applications.
Cell Transplantation,
Journal Year:
2021,
Volume and Issue:
30
Published: Jan. 1, 2021
Traumatic
spinal
cord
injury
(SCI)
results
in
direct
and
indirect
damage
to
neural
tissues,
which
motor
sensory
dysfunction,
dystonia,
pathological
reflex
that
ultimately
lead
paraplegia
or
tetraplegia.
A
loss
of
cells,
axon
regeneration
failure,
time-sensitive
pathophysiology
make
tissue
repair
difficult.
Despite
various
medical
developments,
there
are
currently
no
effective
regenerative
treatments.
Stem
cell
therapy
is
a
promising
treatment
for
SCI
due
its
multiple
targets
reactivity
benefits.
The
present
review
focuses
on
stem
therapy,
including
bone
marrow
mesenchymal
umbilical
adipose-derived
progenitor
embryonic
induced
pluripotent
extracellular
vesicles.
Each
type
certain
features
pathology
shows
therapeutic
effects
via
replacement,
nutritional
support,
scaffolds,
immunomodulation
mechanisms.
However,
many
preclinical
studies
growing
number
clinical
trials
found
single-cell
treatments
had
only
limited
benefits
SCI.
multifaceted,
consensus
combined
needed.
Cells,
Journal Year:
2023,
Volume and Issue:
12(6), P. 853 - 853
Published: March 9, 2023
Spinal
cord
injury
(SCI)
is
a
complex
tissue
resulting
in
permanent
and
degenerating
damage
to
the
central
nervous
system
(CNS).
Detrimental
cellular
processes
occur
after
SCI,
including
axonal
degeneration,
neuronal
loss,
neuroinflammation,
reactive
gliosis,
scar
formation.
The
glial
border
forms
segregate
neural
lesion
isolate
spreading
inflammation,
oxygen
species,
excitotoxicity
at
epicenter
preserve
surrounding
healthy
tissue.
physicochemical
barrier
composed
of
elongated
astrocytes,
fibroblasts,
microglia
secreting
chondroitin
sulfate
proteoglycans,
collogen,
dense
extra-cellular
matrix.
While
this
physiological
response
preserves
viable
tissue,
it
also
detrimental
regeneration.
To
overcome
negative
outcomes
associated
with
formation,
therapeutic
strategies
have
been
developed:
prevention
resolution
developed
scar,
cell
transplantation
into
lesion,
endogenous
reprogramming.
This
review
focuses
on
cellular/molecular
aspects
discusses
advantages
disadvantages
promote
regeneration
SCI.
Biomaterials Science,
Journal Year:
2022,
Volume and Issue:
10(7), P. 1803 - 1811
Published: Jan. 1, 2022
Due
to
the
limited
efficacy
of
current
clinical
treatment
strategies,
functional
recovery
after
traumatic
spinal
cord
injury
(SCI)
remains
a
knotty
problem
be
solved.
Apart
from
anti-inflammation
and
cell
replenishing
treatments,
accumulating
evidence
implies
that
promoting
angiogenesis
would
also
potentially
benefit
tissue
regeneration
SCI.
In
this
research,
inspired
by
role
exosomes
in
cell-cell
communication
exosomal
alteration
resulting
cells
under
stress,
were
engineered
through
hypoxia
stimulation
mesenchymal
stem
proposed
as
an
alternative
for
SCI
therapy.
Hypoxia-stimulated
(hypo-Exo)
transplanted
into
injured
via
encapsulation
peptide-modified
adhesive
hydrogel
pro-angiogenic
therapy
The
peptide
PPFLMLLKGSTR-modified
hyaluronic
acid
replenished
cavity
caused
achieved
local
delivery
exosomes.
hypoxia-inducible
factor
1-alpha
content
hypo-Exo
was
significantly
increased,
overexpression
vascular
endothelial
growth
surrounding
transplant
system.
Ultimately,
prominent
demonstrated
both
vitro
vivo,
indicating
immense
potential
hydrogel-encapsulated
treating
central
nervous
system
trauma
other
ischemia
diseases.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: July 7, 2023
Abstract
The
transplantation
of
mesenchymal
stem
cells-derived
secretome,
particularly
extracellular
vesicles
is
a
promising
therapy
to
suppress
spinal
cord
injury-triggered
neuroinflammation.
However,
efficient
delivery
the
injured
cord,
with
minimal
damage,
remains
challenge.
Here
we
present
device
for
treat
injury.
We
show
that
incorporating
cells
and
porous
microneedles
enables
vesicles.
demonstrate
topical
application
lesion
beneath
dura,
does
not
damage
lesion.
evaluate
efficacy
our
in
contusive
injury
model
find
it
reduces
cavity
scar
tissue
formation,
promotes
angiogenesis,
improves
survival
nearby
tissues
axons.
Importantly,
sustained
at
least
7
days
results
significant
functional
recovery.
Thus,
provides
an
platform
treatment.
ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(4), P. 3818 - 3837
Published: Feb. 14, 2023
Neural
stem
cells
(NSCs)
are
considered
to
be
prospective
replacements
for
neuronal
cell
loss
as
a
result
of
spinal
cord
injury
(SCI).
However,
the
survival
and
differentiation
NSCs
strongly
affected
by
unfavorable
microenvironment
induced
SCI,
which
critically
impairs
their
therapeutic
ability
treat
SCI.
Herein,
strategy
fabricate
PDGF-MP
hydrogel
(PDGF-MPH)
microspheres
(PDGF-MPHM)
instead
bulk
hydrogels
is
proposed
dramatically
enhance
efficiency
platelet-derived
growth
factor
mimetic
peptide
(PDGF-MP)
in
activating
its
receptor.
PDGF-MPHM
were
fabricated
piezoelectric
ceramic-driven
thermal
electrospray
device,
had
an
average
size
9
μm,
also
activate
PDGFRβ
more
effectively
than
PDGF-MPH.
In
vitro,
exerted
strong
neuroprotective
effects
maintaining
proliferation
inhibiting
apoptosis
presence
myelin
extracts.
vivo,
inhibited
M1
macrophage
infiltration
extrinsic
or
intrinsic
on
seventh
day
after
Eight
weeks
T10
SCI
treatment
results
showed
that
+
significantly
promoted
differentiation,
reduced
lesion
size,
considerably
improved
motor
function
recovery
rats
stimulating
axonal
regeneration,
synapse
formation,
angiogenesis
comparison
with
graft
group.
Therefore,
our
findings
provide
insights
into
promising
agent
repair.
Bioactive Materials,
Journal Year:
2023,
Volume and Issue:
25, P. 160 - 175
Published: Feb. 2, 2023
3D
bioprinting
holds
great
promise
toward
fabricating
biomimetic
living
constructs
in
a
bottom-up
assembly
manner.
To
date,
various
emergences
of
have
been
bioprinted
for
Brain,
Journal Year:
2023,
Volume and Issue:
147(3), P. 766 - 793
Published: Nov. 15, 2023
Abstract
Traumatic
spinal
cord
injury
(SCI)
is
a
leading
cause
of
lifelong
disabilities.
Permanent
sensory,
motor
and
autonomic
impairments
after
SCI
are
substantially
attributed
to
degeneration
neurons
axons,
disintegration
neural
network.
To
date,
minimal
regenerative
treatments
available
for
with
an
unmet
need
new
therapies
reconstruct
the
damaged
neuron-glia
network
restore
connectivity
supraspinal
pathways.
Multipotent
precursor
cells
(NPCs)
have
unique
capacity
generate
neurons,
oligodendrocytes
astrocytes.
Due
this
capacity,
NPCs
been
attractive
cell
source
cellular
SCI.
Transplantation
has
extensively
tested
in
preclinical
models
past
two
decades.
These
studies
identified
opportunities
challenges
associated
NPC
therapies.
While
potential
promote
neuroregeneration
through
various
mechanisms,
their
low
long-term
survival
integration
within
host
injured
limit
functional
benefits
NPC-based
address
challenge,
combinatorial
strategies
developed
optimize
outcomes
by
enriching
microenvironment
biomaterials,
genetic
pharmacological
In
review,
we
will
provide
in-depth
discussion
on
recent
advances
We
discuss
modes
actions
mechanism
which
engrafted
contribute
repair
process
recovery.
also
update
current
clinical
trials
technologies
that
facilitated
preparation
medical-grade
human
suitable
transplantation
studies.
Advanced Functional Materials,
Journal Year:
2021,
Volume and Issue:
32(13)
Published: Dec. 1, 2021
Abstract
Spinal
cord
injury
(SCI)
often
leads
to
the
loss
of
motor
and
sensory
functions
is
a
major
challenge
in
neurological
clinical
practice.
Understanding
pathophysiological
changes
inhibitory
microenvironment
crucial
enable
identification
potential
mechanisms
for
functional
restoration
provide
guidance
development
efficient
treatment
repair
strategies.
To
date,
implantation
specifically
functionalized
biomaterials
lesion
area
has
been
shown
help
promote
axon
regeneration
facilitate
neuronal
circuit
generation
by
remolding
SCI
microenvironments.
Moreover,
structural
spinal
through
transplantation
naive
tissue
grafts
from
adult
donors,
artificial
cord‐like
developed
engineering,
3D
printing
will
open
up
new
avenues
treatment.
This
review
focuses
on
dynamic
microenvironments,
repairs,
strategies
restoring
structure
function,
experimental
animal
models,
regenerative
mechanisms,
studies
repair.
The
current
status,
recent
advances,
challenges,
prospects
scaffold‐based
basic
settings
are
summarized
discussed,
reference
that
guide
future
exploration